BRUNI, COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.734
EU - Europa 4.443
AS - Asia 3.944
SA - Sud America 469
AF - Africa 102
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.740
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.644
RU - Federazione Russa 1.540
IT - Italia 1.221
CN - Cina 1.089
SG - Singapore 1.048
HK - Hong Kong 605
PL - Polonia 584
BR - Brasile 373
VN - Vietnam 329
KR - Corea 313
IE - Irlanda 264
SE - Svezia 184
FR - Francia 163
BD - Bangladesh 134
DE - Germania 134
IN - India 124
FI - Finlandia 122
ID - Indonesia 60
GB - Regno Unito 58
JP - Giappone 58
JO - Giordania 51
AR - Argentina 46
CA - Canada 44
CH - Svizzera 44
AU - Australia 42
NL - Olanda 28
IQ - Iraq 26
TR - Turchia 22
ZA - Sudafrica 22
ES - Italia 21
MX - Messico 19
RO - Romania 18
CI - Costa d'Avorio 14
MA - Marocco 13
PK - Pakistan 13
CO - Colombia 12
UA - Ucraina 12
EC - Ecuador 11
TN - Tunisia 10
VE - Venezuela 10
AZ - Azerbaigian 9
NG - Nigeria 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
BJ - Benin 8
EG - Egitto 8
PE - Perù 8
UZ - Uzbekistan 8
JM - Giamaica 7
BE - Belgio 6
KE - Kenya 6
PT - Portogallo 6
LT - Lituania 5
LV - Lettonia 5
SA - Arabia Saudita 5
TW - Taiwan 5
AT - Austria 4
CL - Cile 4
HU - Ungheria 4
NO - Norvegia 4
PA - Panama 4
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IL - Israele 3
LB - Libano 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TH - Thailandia 3
AL - Albania 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BM - Bermuda 1
CG - Congo 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
Totale 14.729
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.256
Ashburn 894
Singapore 788
Warsaw 576
Hong Kong 531
Fairfield 377
Seoul 310
Hefei 277
Dublin 256
Florence 251
San Jose 232
Chandler 226
Woodbridge 201
Beijing 191
Seattle 178
Milan 152
Cambridge 132
Houston 132
Ho Chi Minh City 109
Moscow 105
Wilmington 103
Lawrence 95
Rome 93
Altamura 90
Los Angeles 87
Lauterbourg 83
Buffalo 82
Council Bluffs 71
Princeton 71
The Dalles 64
Helsinki 63
Boston 58
Munich 58
New York 58
Ann Arbor 57
Hanoi 57
Mumbai 50
Shanghai 47
Tokyo 47
Jakarta 43
Kent 40
Melbourne 38
Naples 37
Paris 37
São Paulo 34
Turin 34
Dallas 32
Chicago 31
Turku 29
Pune 28
Bologna 26
Dong Ket 26
Bern 24
Boardman 24
Clifton 23
Guangzhou 22
San Diego 20
Frankfurt am Main 17
Medford 17
Redondo Beach 17
Yubileyny 17
Bengaluru 16
Catania 16
Falls Church 15
London 15
Toronto 15
Abidjan 14
Da Nang 14
Johannesburg 14
Phoenix 14
Shenzhen 13
Bari 12
Cagliari 12
Lappeenranta 12
Rio de Janeiro 12
West Jordan 12
Atlanta 11
Genoa 11
Orem 11
Tianjin 11
Timisoara 11
Belo Horizonte 10
Fiesole 10
Manchester 10
Mexico City 10
Miano 10
Montreal 10
Norwalk 10
Palermo 10
Salt Lake City 10
Brooklyn 9
Haiphong 9
Pisa 9
Redwood City 9
Andover 8
Chennai 8
Cotonou 8
Figino 8
San Francisco 8
Tashkent 8
Totale 9.559
Salva come PNG Salva come JPEG
Nome #
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 365
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 332
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 313
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 280
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 241
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 240
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 232
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 223
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 215
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 213
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 210
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 209
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 205
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 203
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 203
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 202
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 196
Calcinosis in systemic sclerosis: subsets, distribution and complications 192
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 188
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 188
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 188
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 186
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 185
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 182
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 182
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 182
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 181
A systematic review of the literature on nursing sensitive outcomes in scleroderma: towards a structured path led by a nurse case manager 180
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 177
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 175
Antioxidant agents help primary Raynaud's phenomenon 174
The safety of iloprost in systemic sclerosis in a real-life experience 174
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 171
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 169
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 167
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 166
Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort 166
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 164
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 163
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 161
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 161
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 158
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 158
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 157
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 156
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 156
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 155
Oral lactobacillus species in systemic sclerosis 154
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 153
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 153
Prognostic value of lung ultrasound B-lines in systemic sclerosis 152
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 149
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 147
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 146
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 146
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 146
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 145
Avascular bone necrosis: An underestimated complication of systemic sclerosis 144
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 143
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 143
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 142
Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort 138
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 136
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 134
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 132
To develop a definition and validated expert recommendations to diagnose primary heart involvement in systemic sclerosis - preliminary pathway to a T2T approach 132
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 131
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 130
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 129
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates 129
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 129
Stressful life events at the onset and during the evolution of systemic sclerosis 127
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 123
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 123
Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center 123
Treatment of ulcers in systemic sclerosis 120
Recent advances steer the future of systemic sclerosis toward precision medicine 119
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 119
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 112
Digital Ulcers in Systemic Sclerosis 110
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 108
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 102
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 96
Very early and early diagnosis of systemic sclerosis 93
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 91
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 90
Kidney involvement in systemic sclerosis: From pathogenesis to treatment 83
Patients and physicians differently consider severity and outcomes of systemic sclerosis-associated interstitial lung disease: Results of an international survey 70
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjőgren’s syndrome patients 69
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 47
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 34
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 32
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 31
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 19
Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis 17
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort 17
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis 16
Correction to: Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 15
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 10
Totale 14.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022432 12 20 32 20 25 46 8 41 19 27 62 120
2022/20231.168 109 285 61 62 61 169 165 39 102 19 50 46
2023/2024867 21 74 97 50 60 134 50 154 22 113 64 28
2024/20254.509 140 439 254 731 1.089 515 216 380 193 144 179 229
2025/20265.779 622 703 555 514 671 192 628 270 375 354 300 595
Totale 14.933